Cargando…
Health system delay in treatment of multidrug resistant tuberculosis patients in Bangladesh
BACKGROUND: Bangladesh is one of the 27 high burden countries for multidrug resistant tuberculosis listed by the World Health Organization. Delay in multidrug resistant tuberculosis treatment may allow progression of the disease and affect the attempts to curb transmission of drug resistant tubercul...
Autores principales: | Rifat, Mahfuza, Hall, John, Oldmeadow, Christopher, Husain, Ashaque, Milton, Abul Hasnat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647619/ https://www.ncbi.nlm.nih.gov/pubmed/26573825 http://dx.doi.org/10.1186/s12879-015-1253-9 |
Ejemplares similares
-
Factors related to previous tuberculosis treatment of patients with multidrug-resistant tuberculosis in Bangladesh
por: Rifat, Mahfuza, et al.
Publicado: (2015) -
Development of Multidrug Resistant Tuberculosis in Bangladesh: A Case-Control Study on Risk Factors
por: Rifat, Mahfuza, et al.
Publicado: (2014) -
The Multi-Drug Resistant Tuberculosis Diagnosis and Treatment Cascade in Bangladesh
por: Hossain, Sarder Tanzir, et al.
Publicado: (2015) -
Epidemiology of Tuberculosis in an Urban Slum of Dhaka City, Bangladesh
por: Banu, Sayera, et al.
Publicado: (2013) -
Bangladesh arsenic mitigation programs: lessons from the past
por: Milton, Abul Hasnat, et al.
Publicado: (2012)